Search

Search Constraints

You searched for: Author/Creator Horakova, Dana

Search Results

1. 004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis. (23rd August 2021)

2. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long‐Term Comparative Study. Issue 6 (2nd May 2017)

3. A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patients. (November 2016)

5. Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. Issue 1 (February 2016)

6. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS. (5th September 2017)

7. Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes. Issue 8 (27th January 2014)

8. Association of Latitude and Exposure to Ultraviolet B Radiation With Severity of Multiple Sclerosis: An International Registry Study. (14th June 2022)

9. Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study. (18th December 2012)

10. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. (October 2018)